Pharmanutra S.p.A.
PHN.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €522,735 | €545,255 | €602,573 | €729,946 |
| - Cash | €15,620 | €18,925 | €22,051 | €29,409 |
| + Debt | €24,271 | €28,015 | €17,726 | €6,346 |
| Enterprise Value | €531,386 | €554,345 | €598,248 | €706,883 |
| Revenue | €116,148 | €101,034 | €83,394 | €68,144 |
| % Growth | 15% | 21.2% | 22.4% | – |
| Gross Profit | €82,787 | €48,948 | €30,167 | €32,153 |
| % Margin | 71.3% | 48.4% | 36.2% | 47.2% |
| EBITDA | €32,007 | €26,530 | €24,612 | €19,835 |
| % Margin | 27.6% | 26.3% | 29.5% | 29.1% |
| Net Income | €16,609 | €12,832 | €15,048 | €13,771 |
| % Margin | 14.3% | 12.7% | 18% | 20.2% |
| EPS Diluted | 1.73 | 1.33 | 1.56 | 1.42 |
| % Growth | 30.1% | -14.7% | 9.9% | – |
| Operating Cash Flow | €20,501 | €12,092 | €14,466 | €20,413 |
| Capital Expenditures | -€4,251 | -€13,249 | -€23,157 | -€4,987 |
| Free Cash Flow | €16,250 | -€1,157 | -€8,691 | €15,426 |